(Q44972568)

7 December 2017

title

Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine (English)

1 reference

7 December 2017

Catherine J Marsden

1

1 reference

7 December 2017

Simon Knight

2

1 reference

7 December 2017

Daniel C Smith

3

1 reference

7 December 2017

Philip J Day

4

1 reference

7 December 2017

Lynne M Roberts

5

1 reference

7 December 2017

Gary J Phillips

6

1 reference

7 December 2017

J Michael Lord

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

21-22

1 reference

7 December 2017

page(s)

2800-2805

1 reference

Ricin: structure, mode of action, and some current applications.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Toxin entry: retrograde transport through the secretory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Protection against inhalation toxicity of ricin and abrin by immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Ultrastructure of rat lung following inhalation of ricin aerosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

A novel recombinant vaccine which protects mice against ricin intoxication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Ribosome-inactivating proteins up to date

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Maize ribosome-inactivating protein (b-32). Homologs in related species, effects on maize ribosomes, and modulation of activity by pro-peptide deletions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Structure and activity of an active site substitution of ricin A chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

X-ray structure of recombinant ricin A-chain at 1.8 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Expression, purification and characterization of ricin vectors used for exogenous antigen delivery into the MHC class I presentation pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Differences in cytotoxicity of native and engineered RIPs can be used to assess their ability to reach the cytoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Quantification of ricin toxin using a highly sensitive avidin/biotin enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Allergy to castor bean. II. Identification of the major allergens in castor bean seeds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.024

10.1016/J.VACCINE.2004.01.024

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference